Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lynne M Bird

Showing results (41-50 of 120) with videos related to

Pageof 12
Sort By:
American Journal of Medical Genetics. Part A|December 22, 2017
A novel SAMD9 mutation causing MIRAGE syndrome: An expansion and review of phenotype, dysmorphology, and natural historyLauren Jeffries, Hirohito Shima, Weizhen Ji, et al.
Molecular Autism|May 3, 2018
Abnormal coherence and sleep composition in children with Angelman syndrome: a retrospective EEG studyHanna den Bakker, Michael S Sidorov, Zheng Fan, et al.
Annals of Clinical and Translational Neurology|May 28, 2021
Delta power robustly predicts cognitive function in Angelman syndromeLauren M Ostrowski, Elizabeth R Spencer, Lynne M Bird, et al.
Journal of Neurodevelopmental Disorders|July 21, 2017
Erratum to: Delta rhythmicity is a reliable EEG biomarker in Angelman syndrome: a parallel mouse and human analysisMichael S Sidorov, Gina M Deck, Marjan Dolatshahi, et al.
Journal of Neurodevelopmental Disorders|May 16, 2017
Delta rhythmicity is a reliable EEG biomarker in Angelman syndrome: a parallel mouse and human analysisMichael S Sidorov, Gina M Deck, Marjan Dolatshahi, et al.
American Journal of Medical Genetics. Part A|June 24, 2020
Genetic diagnoses and associated anomalies in fetuses prenatally diagnosed with esophageal atresiaMersedeh Rohanizadegan, Sarah Tracy, Carolina I Galarreta, et al.
Orphanet Journal of Rare Diseases|October 24, 2019
A placebo-controlled trial of folic acid and betaine in identical twins with Angelman syndromeJulia Han, Terry Jo Bichell, Stephanie Golden, et al.
American Journal of Medical Genetics. Part A|September 25, 2018
Heterozygous WNT1 variant causing a variable bone phenotypeShatha Alhamdi, Yi-Chien Lee, Shimul Chowdhury, et al.
Molecular Psychiatry|August 15, 2020
Angelman syndrome genotypes manifest varying degrees of clinical severity and developmental impairmentMarius Keute, Meghan T Miller, Michelle L Krishnan, et al.
European Journal of Human Genetics : EJHG|May 25, 2007
Identification of novel deletions of 15q11q13 in Angelman syndrome by array-CGH: molecular characterization and genotype-phenotype correlationsTrilochan Sahoo, Carlos A Bacino, Jennifer R German, et al.
Pageof 12

Showing results (41-50 of 120) with videos related to

Sort By:
Pageof 12
American Journal of Medical Genetics. Part A|December 22, 2017
A novel SAMD9 mutation causing MIRAGE syndrome: An expansion and review of phenotype, dysmorphology, and natural historyLauren Jeffries, Hirohito Shima, Weizhen Ji, et al.
Molecular Autism|May 3, 2018
Abnormal coherence and sleep composition in children with Angelman syndrome: a retrospective EEG studyHanna den Bakker, Michael S Sidorov, Zheng Fan, et al.
Annals of Clinical and Translational Neurology|May 28, 2021
Delta power robustly predicts cognitive function in Angelman syndromeLauren M Ostrowski, Elizabeth R Spencer, Lynne M Bird, et al.
Journal of Neurodevelopmental Disorders|July 21, 2017
Erratum to: Delta rhythmicity is a reliable EEG biomarker in Angelman syndrome: a parallel mouse and human analysisMichael S Sidorov, Gina M Deck, Marjan Dolatshahi, et al.
Journal of Neurodevelopmental Disorders|May 16, 2017
Delta rhythmicity is a reliable EEG biomarker in Angelman syndrome: a parallel mouse and human analysisMichael S Sidorov, Gina M Deck, Marjan Dolatshahi, et al.
American Journal of Medical Genetics. Part A|June 24, 2020
Genetic diagnoses and associated anomalies in fetuses prenatally diagnosed with esophageal atresiaMersedeh Rohanizadegan, Sarah Tracy, Carolina I Galarreta, et al.
Orphanet Journal of Rare Diseases|October 24, 2019
A placebo-controlled trial of folic acid and betaine in identical twins with Angelman syndromeJulia Han, Terry Jo Bichell, Stephanie Golden, et al.
American Journal of Medical Genetics. Part A|September 25, 2018
Heterozygous WNT1 variant causing a variable bone phenotypeShatha Alhamdi, Yi-Chien Lee, Shimul Chowdhury, et al.
Molecular Psychiatry|August 15, 2020
Angelman syndrome genotypes manifest varying degrees of clinical severity and developmental impairmentMarius Keute, Meghan T Miller, Michelle L Krishnan, et al.
European Journal of Human Genetics : EJHG|May 25, 2007
Identification of novel deletions of 15q11q13 in Angelman syndrome by array-CGH: molecular characterization and genotype-phenotype correlationsTrilochan Sahoo, Carlos A Bacino, Jennifer R German, et al.
Pageof 12